Choosing Your Peptide Product Mix

most peptide catalogs are not designed. they accumulate. an operator adds whatever the supplier had, whatever a competitor was running, whatever a customer asked for, and eighteen months later there are twenty two SKUs, six of which produce ninety percent of revenue and sixteen of which quietly consume inventory capital, photography budget, compliance review time, and shelf attention. this article is about designing the thing on purpose.

as with everything in this category: no usage guidance, no protocols, no claims. research-use-only products are described as such. prescription products require licensed providers. not medical or legal advice.

the four jobs every catalog needs filled

stop thinking about products and start thinking about roles. a catalog needs four jobs done, and a SKU that does none of them should not exist.

1. 1.acquire — the product with genuine search demand that justifies spending cold traffic dollars. usually one, sometimes two. it does not need to be your most profitable product; it needs to be the one strangers will buy
2. 2.attach — products that raise order value at essentially zero incremental acquisition cost. these are your margin. two to four of them
3. 3.recur — something with a natural consumption cycle that supports subscription. recurring revenue is the only thing that makes a rising CAC survivable
4. 4.differentiate — a bundle, a blend, or a proprietary format that cannot be price-compared. without this you are a store, not a brand, and stores lose to whoever discounts hardest

audit your current catalog against those four. if a SKU cannot be assigned to one, it is inventory pretending to be a product. we routinely find that half a catalog fails this test, and cutting it improves every remaining metric because capital and attention concentrate.

the math that should drive the decision

product mix is a cash decision and most operators evaluate it emotionally. run the numbers instead.

• —contribution margin per SKU after high-risk processing, testing spend, temperature-controlled fulfillment, and allocated creative production — not gross margin
• —inventory turns per SKU, since capital locked in slow inventory is capital you cannot spend on traffic
• —attach rate and AOV contribution, which is the number that decides whether your acquisition cost is affordable
• —cash conversion cycle including processor hold periods, which in high-risk categories can be brutal and is the number that actually kills growing brands
• —creative cost per SKU, because in a category with constant ad rejections, every product you support has a real ongoing production cost
• —compliance cost per SKU — legal review, testing cadence, labeling, and the ongoing attention each regulatory lane demands

that last two are the ones nobody models. supporting a product means producing creative for it forever and keeping it compliant forever. a SKU doing two percent of revenue is consuming far more than two percent of your team's time.

mixing regulatory lanes without contaminating them

this is the structural decision that most affects your risk, and it needs to be made deliberately rather than discovered later. a med spa can plausibly operate in three lanes at once: a prescription program under licensed providers, consumer products under cosmetic or supplement frameworks, and research-use-only products. each has its own claims set, its own payment processing profile, and its own advertising rules.

the rule is separation. the failure mode is bleed — service language copied onto a consumer PDP, research-use-only products merchandised next to cosmetics, a single email promoting a prescription program and an RUO vial, one checkout flow handling all three. each of those individually is a compliance problem and collectively they take the most restrictive lane's constraints and apply them to your whole business.

1. 1.separate storefronts or clearly separated sections with distinct checkout flows and terms
2. 2.separate approved claims documents per lane, with a named owner for each
3. 3.separate email and sms segments — never one send spanning two lanes
4. 4.separate payment processing where the risk profiles differ, so a problem in one lane cannot freeze the other
5. 5.separate creative review, with a policy checklist per lane that the media team works from

sequencing: what to launch, in what order

the sequence matters as much as the selection, because early SKUs fund later ones and early mistakes constrain everything after.

1. 1.start with the lowest-risk product that has real demand — usually a consumer format under a cosmetic or supplement framework. it gets your payments, fulfillment, and creative engine working with standard processing rates and lower stakes
2. 2.add the acquisition driver once your operational base is proven, and be willing to spend real traffic dollars behind it
3. 3.add attach products immediately after — this is the fastest margin improvement available and it requires no new customers
4. 4.build the subscription anchor once you have observed real reorder timing, not before. subscription designed off guesses churns
5. 5.add proprietary bundles or blends last, once you know which price points and combinations your customers already choose

the common error is inverting this: launching the highest-risk, highest-margin product first because the spreadsheet says it is the most profitable. then payments break, or a processor complaint arrives, and the operator has no working infrastructure and no lower-risk revenue to fall back on.

SKU discipline

adding is easy and it always feels productive. removing is what actually improves the business. set a rule before you need one: any SKU below a defined revenue floor for two consecutive quarters gets cut or justified in writing to you specifically.

when you cut, the gains are immediate and larger than people expect. inventory capital frees up. creative budget concentrates onto products with enough volume for real testing. compliance review shortens. your PDP catalog stops confusing customers with choice. and your team's attention lands on the products that matter. we have seen catalogs cut by forty percent grow revenue in the same quarter.

the LTV question that decides everything

your product mix determines your ltv, and your ltv determines what you can afford to pay for a customer. that is the whole game. a single-SKU brand with no attach and no subscription can only pay a small acquisition cost, which means it can only buy the cheapest traffic, which means it loses every auction to a competitor with a better mix.

so the mix decision is really an auction decision. every attach product, every subscription conversion, every proprietary bundle raises what you can bid. that is how brands that look identical on the surface end up with wildly different growth rates — one of them can pay twice as much for the same customer and still be profitable.

you do not win the ad auction with better creative. you win it with a product mix that lets you outbid everyone and still make money.

the mistakes

1. 1.accumulating SKUs instead of designing a catalog, until half of it is capital pretending to be product
2. 2.launching the highest-risk product first and having no infrastructure or fallback revenue when it breaks
3. 3.mixing regulatory lanes in one storefront, one email, or one checkout, and inheriting the strictest constraints everywhere
4. 4.evaluating SKUs on gross margin instead of contribution margin, inventory turns, and cash conversion
5. 5.never cutting anything, so creative budget and compliance attention stay permanently diluted
6. 6.building subscription before you have observed real reorder timing
7. 7.ignoring that LTV sets your maximum bid, then wondering why acquisition feels impossible

a working template

if you want a starting point: one acquisition driver with genuine compound-level search demand. three attach products merchandised on the PDP, in the cart, and in post-purchase email. one subscription anchor with a real consumption cycle. one proprietary bundle above your best-selling single SKU. nothing else until those five are each pulling weight, fully tested, fully documented, and generating enough volume to justify their own creative testing budget.

that is five to six SKUs. it is a smaller catalog than most operators are comfortable with, and it will make more money than the twenty two you have now.